Related Experiment Video
Updated: Nov 14, 2025
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Management of Germ Cell Tumors in Pediatric Patients
Brent R Weil1, Deborah F Billmire2
1Department of Pediatric Surgery, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Abstract:
Germ cell tumors arise from primordial germ cells. Most develop in the gonads or along midline structures of the body. Genetic aberrations leading to disruption in the molecular signaling responsible for primordial germ cell migration early in development may provide rationale for why germ cell tumors originate in extragonadal locations. Establishing best practices for treating pediatric germ cell tumors remains an area of active investigation. Recent advances focused on limiting toxicities of therapy, identifying new therapies for relapsed and refractory tumors, defining best practices for surgical staging and resection, and developing novel methods to monitor for disease relapse.
Insights
Germ cell tumors originate from primordial germ cells, and genetic changes may explain extragonadal occurrences. Research focuses on improving pediatric germ cell tumor treatments by reducing toxicity and finding new therapies.
Area of Science:
- Oncology
- Developmental Biology
- Genetics
Background:
- Germ cell tumors (GCTs) originate from primordial germ cells.
- Most GCTs occur in gonads, but extragonadal GCTs arise along midline structures.
- Disrupted molecular signaling during early germ cell migration may explain extragonadal GCT origins.
Purpose of the Study:
- To summarize current research and best practices for treating pediatric germ cell tumors.
- To highlight recent advances in managing GCTs, particularly in relapsed or refractory cases.
- To emphasize the ongoing investigation into optimizing GCT treatment protocols.
Main Methods:
- Review of recent advances in pediatric oncology.
- Analysis of therapeutic strategies for germ cell tumors.
- Examination of surgical staging and resection techniques.
- Exploration of novel methods for disease relapse monitoring.
Main Results:
- Focus on reducing treatment toxicities in pediatric GCT patients.
- Development of new therapeutic options for relapsed and refractory GCTs.
- Advancements in surgical management and postsurgical monitoring.
- Identification of key areas for future research in GCT treatment.
Conclusions:
- Establishing optimal treatment protocols for pediatric germ cell tumors is an active area of research.
- Recent progress aims to improve patient outcomes by minimizing treatment side effects and enhancing efficacy.
- Continued investigation is crucial for refining surgical practices and monitoring strategies for GCTs.
